Skip to Main Content
Skip Nav Destination

Vitamin B12 (cobalamin) is essential to mammalian intracellular metabolism. The prevalence of subclinical cobalamin deficiency is higher than previously expected in a general population and, to prevent irreversible neurological damage, an early diagnosis is crucial especially in asymptomatic subjects with serum total vitamin B12 (tB12) concentrations within a common reference interval. Only the transcobalamin–cobalamin complex (holotranscobalamin, holoTC, or active vitamin B12), a minor fraction of circulating tB12, is available for ubiquitous cellular uptake and, therefore, physiologically relevant. Serum tB12 assay, the widely applied standard method, has poor predictive value while, according to several studies, holoTC determination represents an early predictor of changes in cobalamin homeostasis from infancy to old age and, consequently, an early diagnostic tool. In routine assessment of cobalamin status, serum holoTC measurement by commercially available assays allows us to identify asymptomatic subjects at high risk of developing cobalamin deficiency due to physiological conditions and/or lifestyle. This new method of diagnosing subclinical cobalamin deficiency has so far been rarely utilized, particularly by Italian clinicians, even though different studies show the diagnostic role of measuring active B12.

You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal